COVID-19 Impact on Global Infectious Disease Testing Using PCR for IVD Market Insights, Forecast to 2026
Infectious Disease Testing Using PCR for IVD market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing Using PCR for IVD market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Infectious Disease Testing Using PCR for IVD market is segmented into
The Infectious Disease Testing Using PCR for IVD market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infectious Disease Testing Using PCR for IVD market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Infectious Disease Testing Using PCR for IVD Market Share Analysis
Infectious Disease Testing Using PCR for IVD market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Infectious Disease Testing Using PCR for IVD by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Infectious Disease Testing Using PCR for IVD business, the date to enter into the Infectious Disease Testing Using PCR for IVD market, Infectious Disease Testing Using PCR for IVD product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Infectious Disease Testing Using PCR for IVD market is segmented into
- Direct Detection
- Indirect Detection
- Hospitals
- Laboratory
- Other
The Infectious Disease Testing Using PCR for IVD market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infectious Disease Testing Using PCR for IVD market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Infectious Disease Testing Using PCR for IVD Market Share Analysis
Infectious Disease Testing Using PCR for IVD market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Infectious Disease Testing Using PCR for IVD by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Infectious Disease Testing Using PCR for IVD business, the date to enter into the Infectious Disease Testing Using PCR for IVD market, Infectious Disease Testing Using PCR for IVD product introduction, recent developments, etc.
The major vendors covered:
- Thermo Fisher
- BD
- Roche Diagnostics
- Merck
- Siemens Healthineers
- Hologic
- Abbott Laboratories
- BioMerieux
- Cepheid
- Bayer
- Sysmex
- Ortho Clinical Diagnostics
- Qiagen
- Codexis
- Bio-Rad Laboratories
1 STUDY COVERAGE
1.1 Infectious Disease Testing Using PCR for IVD Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Type
1.4.2 Direct Detection
1.4.3 Indirect Detection
1.5 Market by Application
1.5.1 Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Laboratory
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Testing Using PCR for IVD Industry Impact
1.6.1 How the Covid-19 is Affecting the Infectious Disease Testing Using PCR for IVD Industry
1.6.1.1 Infectious Disease Testing Using PCR for IVD Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infectious Disease Testing Using PCR for IVD Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infectious Disease Testing Using PCR for IVD Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Infectious Disease Testing Using PCR for IVD Market Size Estimates and Forecasts
2.1.1 Global Infectious Disease Testing Using PCR for IVD Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Infectious Disease Testing Using PCR for IVD Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Infectious Disease Testing Using PCR for IVD Production Estimates and Forecasts 2015-2026
2.2 Global Infectious Disease Testing Using PCR for IVD Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Infectious Disease Testing Using PCR for IVD Manufacturers Geographical Distribution
2.4 Key Trends for Infectious Disease Testing Using PCR for IVD Markets & Products
2.5 Primary Interviews with Key Infectious Disease Testing Using PCR for IVD Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production Capacity
3.1.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production (2015-2020)
3.1.3 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers Market Share by Production
3.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue
3.2.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Disease Testing Using PCR for IVD Revenue in 2019
3.3 Global Infectious Disease Testing Using PCR for IVD Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INFECTIOUS DISEASE TESTING USING PCR FOR IVD PRODUCTION BY REGIONS
4.1 Global Infectious Disease Testing Using PCR for IVD Historic Market Facts & Figures by Regions
4.1.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Production (2015-2020)
4.1.2 Global Top Infectious Disease Testing Using PCR for IVD Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.2.2 North America Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.3.2 Europe Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
4.4 China
4.4.1 China Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.4.2 China Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.5.2 Japan Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
5 INFECTIOUS DISEASE TESTING USING PCR FOR IVD CONSUMPTION BY REGION
5.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Consumption
5.1.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Consumption (2015-2020)
5.1.2 Global Top Infectious Disease Testing Using PCR for IVD Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Infectious Disease Testing Using PCR for IVD Consumption by Application
5.2.2 North America Infectious Disease Testing Using PCR for IVD Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Infectious Disease Testing Using PCR for IVD Consumption by Application
5.3.2 Europe Infectious Disease Testing Using PCR for IVD Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Application
5.4.2 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Infectious Disease Testing Using PCR for IVD Consumption by Application
5.5.2 Central & South America Infectious Disease Testing Using PCR for IVD Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Application
5.6.2 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Infectious Disease Testing Using PCR for IVD Market Size by Type (2015-2020)
6.1.1 Global Infectious Disease Testing Using PCR for IVD Production by Type (2015-2020)
6.1.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2015-2020)
6.1.3 Infectious Disease Testing Using PCR for IVD Price by Type (2015-2020)
6.2 Global Infectious Disease Testing Using PCR for IVD Market Forecast by Type (2021-2026)
6.2.1 Global Infectious Disease Testing Using PCR for IVD Production Forecast by Type (2021-2026)
6.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Type (2021-2026)
6.2.3 Global Infectious Disease Testing Using PCR for IVD Price Forecast by Type (2021-2026)
6.3 Global Infectious Disease Testing Using PCR for IVD Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Infectious Disease Testing Using PCR for IVD Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Infectious Disease Testing Using PCR for IVD Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Thermo Fisher
8.1.1 Thermo Fisher Corporation Information
8.1.2 Thermo Fisher Overview and Its Total Revenue
8.1.3 Thermo Fisher Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Thermo Fisher Product Description
8.1.5 Thermo Fisher Recent Development
8.2 BD
8.2.1 BD Corporation Information
8.2.2 BD Overview and Its Total Revenue
8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 BD Product Description
8.2.5 BD Recent Development
8.3 Roche Diagnostics
8.3.1 Roche Diagnostics Corporation Information
8.3.2 Roche Diagnostics Overview and Its Total Revenue
8.3.3 Roche Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Roche Diagnostics Product Description
8.3.5 Roche Diagnostics Recent Development
8.4 Merck
8.4.1 Merck Corporation Information
8.4.2 Merck Overview and Its Total Revenue
8.4.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Merck Product Description
8.4.5 Merck Recent Development
8.5 Siemens Healthineers
8.5.1 Siemens Healthineers Corporation Information
8.5.2 Siemens Healthineers Overview and Its Total Revenue
8.5.3 Siemens Healthineers Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Siemens Healthineers Product Description
8.5.5 Siemens Healthineers Recent Development
8.6 Hologic
8.6.1 Hologic Corporation Information
8.6.2 Hologic Overview and Its Total Revenue
8.6.3 Hologic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Hologic Product Description
8.6.5 Hologic Recent Development
8.7 Abbott Laboratories
8.7.1 Abbott Laboratories Corporation Information
8.7.2 Abbott Laboratories Overview and Its Total Revenue
8.7.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Abbott Laboratories Product Description
8.7.5 Abbott Laboratories Recent Development
8.8 BioMerieux
8.8.1 BioMerieux Corporation Information
8.8.2 BioMerieux Overview and Its Total Revenue
8.8.3 BioMerieux Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 BioMerieux Product Description
8.8.5 BioMerieux Recent Development
8.9 Cepheid
8.9.1 Cepheid Corporation Information
8.9.2 Cepheid Overview and Its Total Revenue
8.9.3 Cepheid Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Cepheid Product Description
8.9.5 Cepheid Recent Development
8.10 Bayer
8.10.1 Bayer Corporation Information
8.10.2 Bayer Overview and Its Total Revenue
8.10.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Bayer Product Description
8.10.5 Bayer Recent Development
8.11 Sysmex
8.11.1 Sysmex Corporation Information
8.11.2 Sysmex Overview and Its Total Revenue
8.11.3 Sysmex Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Sysmex Product Description
8.11.5 Sysmex Recent Development
8.12 Ortho Clinical Diagnostics
8.12.1 Ortho Clinical Diagnostics Corporation Information
8.12.2 Ortho Clinical Diagnostics Overview and Its Total Revenue
8.12.3 Ortho Clinical Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Ortho Clinical Diagnostics Product Description
8.12.5 Ortho Clinical Diagnostics Recent Development
8.13 Qiagen
8.13.1 Qiagen Corporation Information
8.13.2 Qiagen Overview and Its Total Revenue
8.13.3 Qiagen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Qiagen Product Description
8.13.5 Qiagen Recent Development
8.14 Codexis
8.14.1 Codexis Corporation Information
8.14.2 Codexis Overview and Its Total Revenue
8.14.3 Codexis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Codexis Product Description
8.14.5 Codexis Recent Development
8.15 Bio-Rad Laboratories
8.15.1 Bio-Rad Laboratories Corporation Information
8.15.2 Bio-Rad Laboratories Overview and Its Total Revenue
8.15.3 Bio-Rad Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Bio-Rad Laboratories Product Description
8.15.5 Bio-Rad Laboratories Recent Development
8.16 Oxford Nanopore
8.16.1 Oxford Nanopore Corporation Information
8.16.2 Oxford Nanopore Overview and Its Total Revenue
8.16.3 Oxford Nanopore Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 Oxford Nanopore Product Description
8.16.5 Oxford Nanopore Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Infectious Disease Testing Using PCR for IVD Regions Forecast by Revenue (2021-2026)
9.2 Global Top Infectious Disease Testing Using PCR for IVD Regions Forecast by Production (2021-2026)
9.3 Key Infectious Disease Testing Using PCR for IVD Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INFECTIOUS DISEASE TESTING USING PCR FOR IVD CONSUMPTION FORECAST BY REGION
10.1 Global Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.2 North America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.3 Europe Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.5 Latin America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Infectious Disease Testing Using PCR for IVD Sales Channels
11.2.2 Infectious Disease Testing Using PCR for IVD Distributors
11.3 Infectious Disease Testing Using PCR for IVD Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Infectious Disease Testing Using PCR for IVD Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Type
1.4.2 Direct Detection
1.4.3 Indirect Detection
1.5 Market by Application
1.5.1 Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Laboratory
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Testing Using PCR for IVD Industry Impact
1.6.1 How the Covid-19 is Affecting the Infectious Disease Testing Using PCR for IVD Industry
1.6.1.1 Infectious Disease Testing Using PCR for IVD Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Infectious Disease Testing Using PCR for IVD Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Infectious Disease Testing Using PCR for IVD Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Infectious Disease Testing Using PCR for IVD Market Size Estimates and Forecasts
2.1.1 Global Infectious Disease Testing Using PCR for IVD Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Infectious Disease Testing Using PCR for IVD Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Infectious Disease Testing Using PCR for IVD Production Estimates and Forecasts 2015-2026
2.2 Global Infectious Disease Testing Using PCR for IVD Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Infectious Disease Testing Using PCR for IVD Manufacturers Geographical Distribution
2.4 Key Trends for Infectious Disease Testing Using PCR for IVD Markets & Products
2.5 Primary Interviews with Key Infectious Disease Testing Using PCR for IVD Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production Capacity
3.1.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production (2015-2020)
3.1.3 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers Market Share by Production
3.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue
3.2.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Disease Testing Using PCR for IVD Revenue in 2019
3.3 Global Infectious Disease Testing Using PCR for IVD Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INFECTIOUS DISEASE TESTING USING PCR FOR IVD PRODUCTION BY REGIONS
4.1 Global Infectious Disease Testing Using PCR for IVD Historic Market Facts & Figures by Regions
4.1.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Production (2015-2020)
4.1.2 Global Top Infectious Disease Testing Using PCR for IVD Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.2.2 North America Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.3.2 Europe Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
4.4 China
4.4.1 China Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.4.2 China Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Infectious Disease Testing Using PCR for IVD Production (2015-2020)
4.5.2 Japan Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
5 INFECTIOUS DISEASE TESTING USING PCR FOR IVD CONSUMPTION BY REGION
5.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Consumption
5.1.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Consumption (2015-2020)
5.1.2 Global Top Infectious Disease Testing Using PCR for IVD Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Infectious Disease Testing Using PCR for IVD Consumption by Application
5.2.2 North America Infectious Disease Testing Using PCR for IVD Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Infectious Disease Testing Using PCR for IVD Consumption by Application
5.3.2 Europe Infectious Disease Testing Using PCR for IVD Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Application
5.4.2 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Infectious Disease Testing Using PCR for IVD Consumption by Application
5.5.2 Central & South America Infectious Disease Testing Using PCR for IVD Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Application
5.6.2 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Infectious Disease Testing Using PCR for IVD Market Size by Type (2015-2020)
6.1.1 Global Infectious Disease Testing Using PCR for IVD Production by Type (2015-2020)
6.1.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2015-2020)
6.1.3 Infectious Disease Testing Using PCR for IVD Price by Type (2015-2020)
6.2 Global Infectious Disease Testing Using PCR for IVD Market Forecast by Type (2021-2026)
6.2.1 Global Infectious Disease Testing Using PCR for IVD Production Forecast by Type (2021-2026)
6.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Type (2021-2026)
6.2.3 Global Infectious Disease Testing Using PCR for IVD Price Forecast by Type (2021-2026)
6.3 Global Infectious Disease Testing Using PCR for IVD Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Infectious Disease Testing Using PCR for IVD Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Infectious Disease Testing Using PCR for IVD Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Thermo Fisher
8.1.1 Thermo Fisher Corporation Information
8.1.2 Thermo Fisher Overview and Its Total Revenue
8.1.3 Thermo Fisher Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Thermo Fisher Product Description
8.1.5 Thermo Fisher Recent Development
8.2 BD
8.2.1 BD Corporation Information
8.2.2 BD Overview and Its Total Revenue
8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 BD Product Description
8.2.5 BD Recent Development
8.3 Roche Diagnostics
8.3.1 Roche Diagnostics Corporation Information
8.3.2 Roche Diagnostics Overview and Its Total Revenue
8.3.3 Roche Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Roche Diagnostics Product Description
8.3.5 Roche Diagnostics Recent Development
8.4 Merck
8.4.1 Merck Corporation Information
8.4.2 Merck Overview and Its Total Revenue
8.4.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Merck Product Description
8.4.5 Merck Recent Development
8.5 Siemens Healthineers
8.5.1 Siemens Healthineers Corporation Information
8.5.2 Siemens Healthineers Overview and Its Total Revenue
8.5.3 Siemens Healthineers Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Siemens Healthineers Product Description
8.5.5 Siemens Healthineers Recent Development
8.6 Hologic
8.6.1 Hologic Corporation Information
8.6.2 Hologic Overview and Its Total Revenue
8.6.3 Hologic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Hologic Product Description
8.6.5 Hologic Recent Development
8.7 Abbott Laboratories
8.7.1 Abbott Laboratories Corporation Information
8.7.2 Abbott Laboratories Overview and Its Total Revenue
8.7.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Abbott Laboratories Product Description
8.7.5 Abbott Laboratories Recent Development
8.8 BioMerieux
8.8.1 BioMerieux Corporation Information
8.8.2 BioMerieux Overview and Its Total Revenue
8.8.3 BioMerieux Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 BioMerieux Product Description
8.8.5 BioMerieux Recent Development
8.9 Cepheid
8.9.1 Cepheid Corporation Information
8.9.2 Cepheid Overview and Its Total Revenue
8.9.3 Cepheid Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Cepheid Product Description
8.9.5 Cepheid Recent Development
8.10 Bayer
8.10.1 Bayer Corporation Information
8.10.2 Bayer Overview and Its Total Revenue
8.10.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Bayer Product Description
8.10.5 Bayer Recent Development
8.11 Sysmex
8.11.1 Sysmex Corporation Information
8.11.2 Sysmex Overview and Its Total Revenue
8.11.3 Sysmex Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Sysmex Product Description
8.11.5 Sysmex Recent Development
8.12 Ortho Clinical Diagnostics
8.12.1 Ortho Clinical Diagnostics Corporation Information
8.12.2 Ortho Clinical Diagnostics Overview and Its Total Revenue
8.12.3 Ortho Clinical Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Ortho Clinical Diagnostics Product Description
8.12.5 Ortho Clinical Diagnostics Recent Development
8.13 Qiagen
8.13.1 Qiagen Corporation Information
8.13.2 Qiagen Overview and Its Total Revenue
8.13.3 Qiagen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Qiagen Product Description
8.13.5 Qiagen Recent Development
8.14 Codexis
8.14.1 Codexis Corporation Information
8.14.2 Codexis Overview and Its Total Revenue
8.14.3 Codexis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Codexis Product Description
8.14.5 Codexis Recent Development
8.15 Bio-Rad Laboratories
8.15.1 Bio-Rad Laboratories Corporation Information
8.15.2 Bio-Rad Laboratories Overview and Its Total Revenue
8.15.3 Bio-Rad Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Bio-Rad Laboratories Product Description
8.15.5 Bio-Rad Laboratories Recent Development
8.16 Oxford Nanopore
8.16.1 Oxford Nanopore Corporation Information
8.16.2 Oxford Nanopore Overview and Its Total Revenue
8.16.3 Oxford Nanopore Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 Oxford Nanopore Product Description
8.16.5 Oxford Nanopore Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Infectious Disease Testing Using PCR for IVD Regions Forecast by Revenue (2021-2026)
9.2 Global Top Infectious Disease Testing Using PCR for IVD Regions Forecast by Production (2021-2026)
9.3 Key Infectious Disease Testing Using PCR for IVD Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INFECTIOUS DISEASE TESTING USING PCR FOR IVD CONSUMPTION FORECAST BY REGION
10.1 Global Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.2 North America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.3 Europe Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.5 Latin America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Infectious Disease Testing Using PCR for IVD Sales Channels
11.2.2 Infectious Disease Testing Using PCR for IVD Distributors
11.3 Infectious Disease Testing Using PCR for IVD Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Infectious Disease Testing Using PCR for IVD Key Market Segments in This Study
Table 2. Ranking of Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Direct Detection
Table 5. Major Manufacturers of Indirect Detection
Table 6. COVID-19 Impact Global Market: (Four Infectious Disease Testing Using PCR for IVD Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Infectious Disease Testing Using PCR for IVD Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Infectious Disease Testing Using PCR for IVD Players to Combat Covid-19 Impact
Table 11. Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Infectious Disease Testing Using PCR for IVD Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infectious Disease Testing Using PCR for IVD by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing Using PCR for IVD as of 2019)
Table 15. Infectious Disease Testing Using PCR for IVD Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Infectious Disease Testing Using PCR for IVD Product Offered
Table 17. Date of Manufacturers Enter into Infectious Disease Testing Using PCR for IVD Market
Table 18. Key Trends for Infectious Disease Testing Using PCR for IVD Markets & Products
Table 19. Main Points Interviewed from Key Infectious Disease Testing Using PCR for IVD Players
Table 20. Global Infectious Disease Testing Using PCR for IVD Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Infectious Disease Testing Using PCR for IVD Production Share by Manufacturers (2015-2020)
Table 22. Infectious Disease Testing Using PCR for IVD Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Infectious Disease Testing Using PCR for IVD Revenue Share by Manufacturers (2015-2020)
Table 24. Infectious Disease Testing Using PCR for IVD Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Testing Using PCR for IVD Production by Regions (2015-2020) (K Units)
Table 27. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Regions (2015-2020)
Table 28. Global Infectious Disease Testing Using PCR for IVD Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Regions (2015-2020)
Table 30. Key Infectious Disease Testing Using PCR for IVD Players in North America
Table 31. Import & Export of Infectious Disease Testing Using PCR for IVD in North America (K Units)
Table 32. Key Infectious Disease Testing Using PCR for IVD Players in Europe
Table 33. Import & Export of Infectious Disease Testing Using PCR for IVD in Europe (K Units)
Table 34. Key Infectious Disease Testing Using PCR for IVD Players in China
Table 35. Import & Export of Infectious Disease Testing Using PCR for IVD in China (K Units)
Table 36. Key Infectious Disease Testing Using PCR for IVD Players in Japan
Table 37. Import & Export of Infectious Disease Testing Using PCR for IVD in Japan (K Units)
Table 38. Global Infectious Disease Testing Using PCR for IVD Consumption by Regions (2015-2020) (K Units)
Table 39. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Regions (2015-2020)
Table 40. North America Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 41. North America Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 43. Europe Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 51. Global Infectious Disease Testing Using PCR for IVD Production by Type (2015-2020) (K Units)
Table 52. Global Infectious Disease Testing Using PCR for IVD Production Share by Type (2015-2020)
Table 53. Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2015-2020) (Million US$)
Table 54. Global Infectious Disease Testing Using PCR for IVD Revenue Share by Type (2015-2020)
Table 55. Infectious Disease Testing Using PCR for IVD Price by Type 2015-2020 (USD/Unit)
Table 56. Global Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 57. Global Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 58. Global Infectious Disease Testing Using PCR for IVD Consumption Share by Application (2015-2020)
Table 59. Thermo Fisher Corporation Information
Table 60. Thermo Fisher Description and Major Businesses
Table 61. Thermo Fisher Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Thermo Fisher Product
Table 63. Thermo Fisher Recent Development
Table 64. BD Corporation Information
Table 65. BD Description and Major Businesses
Table 66. BD Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. BD Product
Table 68. BD Recent Development
Table 69. Roche Diagnostics Corporation Information
Table 70. Roche Diagnostics Description and Major Businesses
Table 71. Roche Diagnostics Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Roche Diagnostics Product
Table 73. Roche Diagnostics Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Siemens Healthineers Corporation Information
Table 80. Siemens Healthineers Description and Major Businesses
Table 81. Siemens Healthineers Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Siemens Healthineers Product
Table 83. Siemens Healthineers Recent Development
Table 84. Hologic Corporation Information
Table 85. Hologic Description and Major Businesses
Table 86. Hologic Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Hologic Product
Table 88. Hologic Recent Development
Table 89. Abbott Laboratories Corporation Information
Table 90. Abbott Laboratories Description and Major Businesses
Table 91. Abbott Laboratories Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Abbott Laboratories Product
Table 93. Abbott Laboratories Recent Development
Table 94. BioMerieux Corporation Information
Table 95. BioMerieux Description and Major Businesses
Table 96. BioMerieux Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. BioMerieux Product
Table 98. BioMerieux Recent Development
Table 99. Cepheid Corporation Information
Table 100. Cepheid Description and Major Businesses
Table 101. Cepheid Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Cepheid Product
Table 103. Cepheid Recent Development
Table 104. Bayer Corporation Information
Table 105. Bayer Description and Major Businesses
Table 106. Bayer Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Bayer Product
Table 108. Bayer Recent Development
Table 109. Sysmex Corporation Information
Table 110. Sysmex Description and Major Businesses
Table 111. Sysmex Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sysmex Product
Table 113. Sysmex Recent Development
Table 114. Ortho Clinical Diagnostics Corporation Information
Table 115. Ortho Clinical Diagnostics Description and Major Businesses
Table 116. Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Ortho Clinical Diagnostics Product
Table 118. Ortho Clinical Diagnostics Recent Development
Table 119. Qiagen Corporation Information
Table 120. Qiagen Description and Major Businesses
Table 121. Qiagen Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Qiagen Product
Table 123. Qiagen Recent Development
Table 124. Codexis Corporation Information
Table 125. Codexis Description and Major Businesses
Table 126. Codexis Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Codexis Product
Table 128. Codexis Recent Development
Table 129. Bio-Rad Laboratories Corporation Information
Table 130. Bio-Rad Laboratories Description and Major Businesses
Table 131. Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Bio-Rad Laboratories Product
Table 133. Bio-Rad Laboratories Recent Development
Table 134. Oxford Nanopore Corporation Information
Table 135. Oxford Nanopore Description and Major Businesses
Table 136. Oxford Nanopore Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Oxford Nanopore Product
Table 138. Oxford Nanopore Recent Development
Table 139. Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Region (2021-2026) (Million US$)
Table 140. Global Infectious Disease Testing Using PCR for IVD Production Forecast by Regions (2021-2026) (K Units)
Table 141. Global Infectious Disease Testing Using PCR for IVD Production Forecast by Type (2021-2026) (K Units)
Table 142. Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Type (2021-2026) (Million US$)
Table 143. North America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 144. Europe Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 145. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 146. Latin America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 147. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 148. Infectious Disease Testing Using PCR for IVD Distributors List
Table 149. Infectious Disease Testing Using PCR for IVD Customers List
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 1. Infectious Disease Testing Using PCR for IVD Key Market Segments in This Study
Table 2. Ranking of Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Direct Detection
Table 5. Major Manufacturers of Indirect Detection
Table 6. COVID-19 Impact Global Market: (Four Infectious Disease Testing Using PCR for IVD Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Infectious Disease Testing Using PCR for IVD Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Infectious Disease Testing Using PCR for IVD Players to Combat Covid-19 Impact
Table 11. Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Infectious Disease Testing Using PCR for IVD Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infectious Disease Testing Using PCR for IVD by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing Using PCR for IVD as of 2019)
Table 15. Infectious Disease Testing Using PCR for IVD Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Infectious Disease Testing Using PCR for IVD Product Offered
Table 17. Date of Manufacturers Enter into Infectious Disease Testing Using PCR for IVD Market
Table 18. Key Trends for Infectious Disease Testing Using PCR for IVD Markets & Products
Table 19. Main Points Interviewed from Key Infectious Disease Testing Using PCR for IVD Players
Table 20. Global Infectious Disease Testing Using PCR for IVD Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Infectious Disease Testing Using PCR for IVD Production Share by Manufacturers (2015-2020)
Table 22. Infectious Disease Testing Using PCR for IVD Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Infectious Disease Testing Using PCR for IVD Revenue Share by Manufacturers (2015-2020)
Table 24. Infectious Disease Testing Using PCR for IVD Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Testing Using PCR for IVD Production by Regions (2015-2020) (K Units)
Table 27. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Regions (2015-2020)
Table 28. Global Infectious Disease Testing Using PCR for IVD Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Regions (2015-2020)
Table 30. Key Infectious Disease Testing Using PCR for IVD Players in North America
Table 31. Import & Export of Infectious Disease Testing Using PCR for IVD in North America (K Units)
Table 32. Key Infectious Disease Testing Using PCR for IVD Players in Europe
Table 33. Import & Export of Infectious Disease Testing Using PCR for IVD in Europe (K Units)
Table 34. Key Infectious Disease Testing Using PCR for IVD Players in China
Table 35. Import & Export of Infectious Disease Testing Using PCR for IVD in China (K Units)
Table 36. Key Infectious Disease Testing Using PCR for IVD Players in Japan
Table 37. Import & Export of Infectious Disease Testing Using PCR for IVD in Japan (K Units)
Table 38. Global Infectious Disease Testing Using PCR for IVD Consumption by Regions (2015-2020) (K Units)
Table 39. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Regions (2015-2020)
Table 40. North America Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 41. North America Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 43. Europe Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Countries (2015-2020) (K Units)
Table 51. Global Infectious Disease Testing Using PCR for IVD Production by Type (2015-2020) (K Units)
Table 52. Global Infectious Disease Testing Using PCR for IVD Production Share by Type (2015-2020)
Table 53. Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2015-2020) (Million US$)
Table 54. Global Infectious Disease Testing Using PCR for IVD Revenue Share by Type (2015-2020)
Table 55. Infectious Disease Testing Using PCR for IVD Price by Type 2015-2020 (USD/Unit)
Table 56. Global Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 57. Global Infectious Disease Testing Using PCR for IVD Consumption by Application (2015-2020) (K Units)
Table 58. Global Infectious Disease Testing Using PCR for IVD Consumption Share by Application (2015-2020)
Table 59. Thermo Fisher Corporation Information
Table 60. Thermo Fisher Description and Major Businesses
Table 61. Thermo Fisher Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Thermo Fisher Product
Table 63. Thermo Fisher Recent Development
Table 64. BD Corporation Information
Table 65. BD Description and Major Businesses
Table 66. BD Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. BD Product
Table 68. BD Recent Development
Table 69. Roche Diagnostics Corporation Information
Table 70. Roche Diagnostics Description and Major Businesses
Table 71. Roche Diagnostics Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Roche Diagnostics Product
Table 73. Roche Diagnostics Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Siemens Healthineers Corporation Information
Table 80. Siemens Healthineers Description and Major Businesses
Table 81. Siemens Healthineers Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Siemens Healthineers Product
Table 83. Siemens Healthineers Recent Development
Table 84. Hologic Corporation Information
Table 85. Hologic Description and Major Businesses
Table 86. Hologic Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Hologic Product
Table 88. Hologic Recent Development
Table 89. Abbott Laboratories Corporation Information
Table 90. Abbott Laboratories Description and Major Businesses
Table 91. Abbott Laboratories Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Abbott Laboratories Product
Table 93. Abbott Laboratories Recent Development
Table 94. BioMerieux Corporation Information
Table 95. BioMerieux Description and Major Businesses
Table 96. BioMerieux Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. BioMerieux Product
Table 98. BioMerieux Recent Development
Table 99. Cepheid Corporation Information
Table 100. Cepheid Description and Major Businesses
Table 101. Cepheid Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Cepheid Product
Table 103. Cepheid Recent Development
Table 104. Bayer Corporation Information
Table 105. Bayer Description and Major Businesses
Table 106. Bayer Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Bayer Product
Table 108. Bayer Recent Development
Table 109. Sysmex Corporation Information
Table 110. Sysmex Description and Major Businesses
Table 111. Sysmex Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sysmex Product
Table 113. Sysmex Recent Development
Table 114. Ortho Clinical Diagnostics Corporation Information
Table 115. Ortho Clinical Diagnostics Description and Major Businesses
Table 116. Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Ortho Clinical Diagnostics Product
Table 118. Ortho Clinical Diagnostics Recent Development
Table 119. Qiagen Corporation Information
Table 120. Qiagen Description and Major Businesses
Table 121. Qiagen Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Qiagen Product
Table 123. Qiagen Recent Development
Table 124. Codexis Corporation Information
Table 125. Codexis Description and Major Businesses
Table 126. Codexis Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Codexis Product
Table 128. Codexis Recent Development
Table 129. Bio-Rad Laboratories Corporation Information
Table 130. Bio-Rad Laboratories Description and Major Businesses
Table 131. Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Bio-Rad Laboratories Product
Table 133. Bio-Rad Laboratories Recent Development
Table 134. Oxford Nanopore Corporation Information
Table 135. Oxford Nanopore Description and Major Businesses
Table 136. Oxford Nanopore Infectious Disease Testing Using PCR for IVD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Oxford Nanopore Product
Table 138. Oxford Nanopore Recent Development
Table 139. Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Region (2021-2026) (Million US$)
Table 140. Global Infectious Disease Testing Using PCR for IVD Production Forecast by Regions (2021-2026) (K Units)
Table 141. Global Infectious Disease Testing Using PCR for IVD Production Forecast by Type (2021-2026) (K Units)
Table 142. Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Type (2021-2026) (Million US$)
Table 143. North America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 144. Europe Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 145. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 146. Latin America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 147. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Forecast by Regions (2021-2026) (K Units)
Table 148. Infectious Disease Testing Using PCR for IVD Distributors List
Table 149. Infectious Disease Testing Using PCR for IVD Customers List
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Infectious Disease Testing Using PCR for IVD Product Picture
Figure 2. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Type in 2020 & 2026
Figure 3. Direct Detection Product Picture
Figure 4. Indirect Detection Product Picture
Figure 5. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Laboratory
Figure 8. Other
Figure 9. Infectious Disease Testing Using PCR for IVD Report Years Considered
Figure 10. Global Infectious Disease Testing Using PCR for IVD Revenue 2015-2026 (Million US$)
Figure 11. Global Infectious Disease Testing Using PCR for IVD Production Capacity 2015-2026 (K Units)
Figure 12. Global Infectious Disease Testing Using PCR for IVD Production 2015-2026 (K Units)
Figure 13. Global Infectious Disease Testing Using PCR for IVD Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Infectious Disease Testing Using PCR for IVD Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by Infectious Disease Testing Using PCR for IVD Revenue in 2019
Figure 17. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Region (2015-2020)
Figure 18. Infectious Disease Testing Using PCR for IVD Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. Infectious Disease Testing Using PCR for IVD Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. Infectious Disease Testing Using PCR for IVD Production Growth Rate in China (2015-2020) (K Units)
Figure 23. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. Infectious Disease Testing Using PCR for IVD Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Regions 2015-2020
Figure 27. North America Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 29. North America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 30. U.S. Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 34. Europe Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 35. Germany Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 42. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Market Share by Regions in 2019
Figure 43. China Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (K Units)
Figure 55. Latin America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 56. Latin America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 57. Mexico Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 63. Turkey Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Type (2015-2020)
Figure 67. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Type in 2019
Figure 68. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type (2015-2020)
Figure 69. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type in 2019
Figure 70. Global Infectious Disease Testing Using PCR for IVD Production Market Share Forecast by Type (2021-2026)
Figure 71. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global Infectious Disease Testing Using PCR for IVD Market Share by Price Range (2015-2020)
Figure 73. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application (2015-2020)
Figure 74. Global Infectious Disease Testing Using PCR for IVD Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share Forecast by Application (2021-2026)
Figure 76. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Ortho Clinical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Codexis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Oxford Nanopore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 93. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share Forecast by Regions ((2021-2026))
Figure 94. Global Infectious Disease Testing Using PCR for IVD Production Forecast by Regions (2021-2026) (K Units)
Figure 95. North America Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 96. North America Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Europe Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 98. Europe Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 99. China Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 100. China Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 101. Japan Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 102. Japan Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 103. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share Forecast by Region (2021-2026)
Figure 104. Infectious Disease Testing Using PCR for IVD Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
Figure 1. Infectious Disease Testing Using PCR for IVD Product Picture
Figure 2. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Type in 2020 & 2026
Figure 3. Direct Detection Product Picture
Figure 4. Indirect Detection Product Picture
Figure 5. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Laboratory
Figure 8. Other
Figure 9. Infectious Disease Testing Using PCR for IVD Report Years Considered
Figure 10. Global Infectious Disease Testing Using PCR for IVD Revenue 2015-2026 (Million US$)
Figure 11. Global Infectious Disease Testing Using PCR for IVD Production Capacity 2015-2026 (K Units)
Figure 12. Global Infectious Disease Testing Using PCR for IVD Production 2015-2026 (K Units)
Figure 13. Global Infectious Disease Testing Using PCR for IVD Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Infectious Disease Testing Using PCR for IVD Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by Infectious Disease Testing Using PCR for IVD Revenue in 2019
Figure 17. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Region (2015-2020)
Figure 18. Infectious Disease Testing Using PCR for IVD Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. Infectious Disease Testing Using PCR for IVD Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. Infectious Disease Testing Using PCR for IVD Production Growth Rate in China (2015-2020) (K Units)
Figure 23. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. Infectious Disease Testing Using PCR for IVD Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Regions 2015-2020
Figure 27. North America Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 29. North America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 30. U.S. Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 34. Europe Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 35. Germany Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 42. Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Market Share by Regions in 2019
Figure 43. China Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (K Units)
Figure 55. Latin America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 56. Latin America Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 57. Mexico Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Market Share by Countries in 2019
Figure 63. Turkey Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E Infectious Disease Testing Using PCR for IVD Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Type (2015-2020)
Figure 67. Global Infectious Disease Testing Using PCR for IVD Production Market Share by Type in 2019
Figure 68. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type (2015-2020)
Figure 69. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type in 2019
Figure 70. Global Infectious Disease Testing Using PCR for IVD Production Market Share Forecast by Type (2021-2026)
Figure 71. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global Infectious Disease Testing Using PCR for IVD Market Share by Price Range (2015-2020)
Figure 73. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share by Application (2015-2020)
Figure 74. Global Infectious Disease Testing Using PCR for IVD Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share Forecast by Application (2021-2026)
Figure 76. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Ortho Clinical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Codexis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Oxford Nanopore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 93. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share Forecast by Regions ((2021-2026))
Figure 94. Global Infectious Disease Testing Using PCR for IVD Production Forecast by Regions (2021-2026) (K Units)
Figure 95. North America Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 96. North America Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Europe Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 98. Europe Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 99. China Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 100. China Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 101. Japan Infectious Disease Testing Using PCR for IVD Production Forecast (2021-2026) (K Units)
Figure 102. Japan Infectious Disease Testing Using PCR for IVD Revenue Forecast (2021-2026) (US$ Million)
Figure 103. Global Infectious Disease Testing Using PCR for IVD Consumption Market Share Forecast by Region (2021-2026)
Figure 104. Infectious Disease Testing Using PCR for IVD Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
